July 5, 2013 9:29 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating and $41.00 price target on
Molina Healthcare (NYSE: MOH).In the report, Bank of America noted, “On 7/3/13 MOH announced it had entered an agreement to assume Lovelace Community Health Plan's New Mexico Medicaid managed care contract covering 84k residents, in a transaction we estimate could add 2-4% to EPS over time. Lovelace was not selected to participate in New Mexico's Centennial Care program and appears to have elected to transition the membership to MOH a few months before their current contract expires. MOH anticipates completing the transaction on 8/1/13. MOH was already the second largest Managed Medicaid company in the state with 91k enrollees, and this agreement will bring in line with Presbyterian Health Plan, the market leader. MOH should be able to leverage its existing infrastructure and SG&A in the state to help boost profit margins.”Molina Healthcare closed on Wednesday at $37.81.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.